Drug Type Small molecule drug |
Synonyms DPT PEP2, PEP 030 |
Target |
Mechanism CRAF inhibitors(C-Raf kinase inhibitors), RAS inhibitors(RAS type GTPase family inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization PEP-Therapy SASStartup |
Active Organization- |
Inactive Organization PEP-Therapy SASStartup |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | FR | PEP-Therapy SASStartup | - |